Congruent with the above findings, acute myeloid leukemia (AML) patients who achieved complete remission were found to have a higher proportion of PD-L1+ NK cells at complete remission compared to at the time of diagnosis as well as compared to AML patients who failed to reach complete remission (25). This evidence concerns the gene CD274 and acute myeloid leukemia.